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Experimenting new drugs on human beings, is one of the 
crucial human right issues faced by the third world 
countries in the present century. It is true that the 
international law had taken high concern of this social 
issue after the Nuremberg Trials. The international law 
mandates informed consent to be obtained from the 
participants of clinical trials and this is the sole 
mechanism through which the rights of the trial subjects 
are being protected. The public health issues caused by 
illegal and unethical trials over patients are now evident 
in Indian health care system. The issue has come up for 
consideration before the Supreme Court of India recently. 
In India the law runs in tune with the international 
parameters for conducting human experimentation. The 
law on informed consent has a fatal impact over public 
health care issues, especially over the matter of clinical 
trials. Recent experiences in India reveal the threats 
caused to the society by clinical experimentations. Clinical 
trials and allied health issues are also brought to the 
notice of the judiciary. The law on informed consent in 
India is in its infant state. Exploring the doctrine of 
informed consent is crucial to this study. The present 
issue of clinical research which threatens the health care 
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system is analysed and the doctrine of informed consent 
to regulate the system is assessed to check its efficacy and 
veracity. Analysis of the issue will help to communicate to 
the public about the need for better exercise of the rights 
of those who are subjected to clinical researches. The law 
of informed consent is in many ways inadequate to deal 
with the issues relating to clinical trials in India. The 
doctrine of informed consent has to be redefined to a 
great extent. The institutional review boards and Non-
Government Organisations (NGO) can play a vital role in 
assuring proper observation of rules relating to regulation 
of human trials. 
Keywords: Clinical Trials, Consent, Ethics, Experimentation, 
Health.  
Introduction 
Medical experimentations are something that takes place in every 
doctor‟s office. 1  These researches always involve high risk and 
responsibilities.2 The law prescribes that the voluntary consent of 
the trial subject is always essential for the experimentations.3 The 
laws made after the Nuremberg trial demands for the procurement 
of full consent from the trial subjects for conducting human 
experimentations. The Nuremberg code mentions it as voluntary 
consent and at present the rule has developed into informed 
consent. It is the duty of the physicians to appraise the trial subjects 
about the experimentations in detail. The consequences of being a 
party to the trial should be made known to the patient and with 
such knowledge in mind; the subject has to provide his consent. 
Thus the informed consent derived from a patient or trial subject 
has manifold implications over the entire process of human 
experimentation. Informed consent can thus be called as the 
elementary and imperative clause that regulates the entire process 
of human experimentation. 
                                                          
1 Michael B. Shimkin, The Problem of Experimentation on Human Beings, 117 
SCIENCE NEW SERIES, 205 (1953). 
2 Id.  
3 See The Nuremberg Code, Trials of War Criminals before the Nuremberg 
Military Tribunals, 2 Control Council Law No. 10, 181 (1947). 
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Jurisprudence of Informed Consent 
The term informed consent was not used by the Nuremberg Code 
but first appeared in the Helsinki Declaration 1964. 4  The 
declaration also gave the power to a trial subject to withdraw the 
consent at any time during the trial and to abstain himself from any 
further experimentations. To know the relevance and meaning of 
informed consent it is equally important to understand the role 
played by the doctrine in physician-patient relationship. Patient‟s 
right to know about the disease, treatment and its impact over life 
is well related to his quality of life.5 In the health care system, the 
concept of quality of life is an age old doctrine and well approved 
since the time of Greeks.6 In every case, the need of any patient is to 
have some affirmative action in preserving his life. This aspiration 
of a patient entitles him with the right to know about the kind of 
treatment administered to him. This aspiration is justified with the 
help of the hedonistic theory.7 The concept of good life and its 
effects on the quality of life is well addressed by hedonistic theory. 
The hedonistic calculus demands the health care system to offer 
maximum assurance to the quality of life so as to increase its utility.  
The patient‟s right to decide the outcome of his treatment is also a 
concern of informed consent. This proposition can be understood in 
situations of terminal illness. If no fruitful treatment is available, it 
is the right of the patient to decide for prolonged medication and 
treatment. This decision making power cannot always be 
recognized as a unique standard for the health care system. The 
power to exercise the right depends upon the gravity of the disease. 
For example in case of a cardiac arrest or a severe injury by motor 
accidents the patient may not be in a position to take an 
appropriate decision. However in most of the other cases, 
especially where options are available to a patient, he can make his 
                                                          
4See World Medical Association, Helsinki Declaration, (1964) Principles 22 
& 23, available at http://www.wma.net/en/30publications/10policies/ 
b3/17c.pdf.  
5  Ivan Barofsky, Patients’ Rights, Quality of Life and Health Care System 
Performance, 12 QUALITY OF LIFE RESEARCH 473, 481 (2003). 
6Id. at 475. 
7Id.  
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choice. The decision making power plays a vital role here as the 
physician prescribes a new method of cure where a known science 
is available. The decision made by the patient on the explanations 
given by a physician still casts some dilemma. The way in which 
the physician‟s explanations get into the mind of a trial subject is 
perplexing.8 
Apart from the above reasoning, the need for consent is also 
evident from the doctrine of body autonomy. Human body is also 
recognized by law as a property and any interference with the body 
material against one‟s consent would amount to trespass and hence 
constitutes a criminal offence. It can always risk subject‟s health 
and life and is thus a matter of great concern.9  Autonomy is one of 
the fundamental values that should regulate any kind of 
experimentation over human subjects. The doctrine of informed 
consent completely relies on autonomy. Central to the concept of 
autonomy is the idea that people should be able to rule themselves 
rather than be ruled by others. The Kantian conception of man as 
an end in himself can be read with the concept of autonomy.   
Law discusses about two different concept of autonomy. One is the 
libertarian concept and another one is the liberal concept of 
autonomy. In the libertarian conception the state or any private 
interest will violate the right to autonomy while interfering with 
the decision making power of a person unless and until the 
decision amounts to a public wrong. This kind of approach does 
not have any paternalistic concern for the subject‟s right. On the 
other hand, the liberal concept is wedded with this paternalistic 
concern. Informed consent is addressed as liberal concept of 
autonomy.  The law demands the consent to be informed, as it has 
a paternal care towards its subjects. On the other hand, the 
libertarianism stands for the actual consent of the subject 
irrespective of the fact how far it is informed. Thus the concept of 
autonomy has facilitated the construction of the doctrine of 
informed consent. The entire process of human experimentation 
                                                          
8 J. K. Wing, The Ethics of Clinical Trials, 1 J. MED. ETHICS 174 (1975).  
9 M. Cheriff Bassiouni et. al., An Appraisal of Human Experimentation in 
International Law and Practice: The Need for International Regulation of Human 
Experimentation, 72 J. CRIM. L. & CRIMINOLOGY 1597, 1603 (1981). 
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starts with the availability of volunteers for trials and this can be 
initiated by availing consent from the trial subjects.  
Informed Consent: The Legal Formalities 
From the Nuremberg Code and the Helsinki Declaration, informed 
consent is accepted as one of the prominent rule for human 
bioethics. The need for consent is also declared mandatory by the 
recent U.N. Documents.10 It demands for providing all adequate 
information with respect to the kind of treatment or 
experimentation done over a person.11 Apart from this it is also 
mandated that such trial subjects will be entitled with the right to 
withdraw their consent.12 The declaration also emphasises on the 
inter relation between the human dignity, medical ethics and 
informed consent. It is internationally recognized that the waiver of 
informed consent cannot be made ordinarily but in all exceptional 
cases, the investigator has to get the approval from ethical review 
committee. 13  This guideline in its commentary also attempts to 
draw an international definition for the term informed consent. It 
states that, “Informed consent is a decision to participate in 
research, taken by a competent individual who has received the 
necessary information; who has adequately understood the 
information; and who, after considering the information, has 
arrived at a decision without having been subjected to coercion, 
undue influence, inducement or intimidation”.14 
Thus the concept of contracting can be read into the makeup of 
every informed consent. The consent should be free from any kind 
of influences. The freedom of choice based on individual autonomy 
is the principle behind the entire concept of informed consent. Two 
or more persons are said to consent when they agree upon the 
                                                          
10 Universal Declaration on Bioethics and Human Rights, U.N.E.S.C.O., 
U.N. Doc. A/RES/2005/6 (Oct. 19, 2005). 
11 Id. 
12 Id. 
13  COUNCIL OF INTERNATIONAL ORGANIZATIONS FOR MEDICAL SCIENCES, 
INTERNATIONAL ETHICAL GUIDELINES FOR BIOMEDICAL RESEARCH 
INVOLVING HUMAN SUBJECTS 50 (2002). 
14 Id. 
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same thing in the same sense. 15  While making a contract, the 
consent should not be caused by coercion, undue influence, fraud, 
misrepresentation or mistake. 16  The consent thus made will be 
treated as informed when it is an act of reason accompanied by 
deliberation of mind which can know the right and wrong, good 
and evil. Thus informed consent will represent the active will of the 
person who makes the consent. 
In the case of medical law, consent will operate more as an ethical 
doctrine than as a legal norm. Informed consent attains such a 
shape by virtue of the fact that it has tremendous impact over the 
individual dignity and their self determination capacity. Seeking 
consent tries to create the optimal relationship between doctor and 
patient, namely a partnership of shared endeavour in pursuit of the 
client‟s interests.17 The entire procedure of consenting in medical 
law involves high reverence towards personal autonomy. From this 
perception it is evident that a doctor cannot even touch his patient 
without his consent. The doctrine of informed consent signifies 
consent of patient obtained after true and full disclosure of 
information regarding diagnosis, alternative methods of treatment 
with their relative risks and benefits and known material risks of 
procedure. 18  As the doctrine encompasses all the details of the 
disease and possible ways of cure, it makes one of the most 
relevant procedures in case of drug trials and any form of human 
experimentations. In any case of treatment, if the consent from a 
patient is extracted without the proper disclosure of material facts 
of treatment, the consent so obtained will be regarded as legally 
invalid. Defective or inadequate information of treatment will 
disable the patient to make his rational judgment in submitting 
oneself to treatment. 
As per the old doctrine from the Hippocratic Corpus, every physician 
had to conceal many things from the patient which appeared to be 
                                                          
15 The Indian Contract Act, 1872, § 13. 
16  NILIMA BHADBHADE, POLLOCK & MULLA, THE INDIAN CONTRACT AND 
SPECIFIC RELIEF ACTS  398 (Butterworth 12th ed. 2001). 
17 IAN KENNEDY, TREAT ME RIGHT: ESSAYS IN MEDICAL LAW AND ETHICS 178 
(Clarendon Press Oxford, 1991). 
18 Gerald Robertson, Informed Consent to Medical Treatment, 97 L.Q.R. 102 
(1981). 
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prejudicial to the patient‟s health or wellbeing. 19 However new 
concept of trust and good faith underlies the doctor-patient 
relationship. On the one side, it is argued that the main reason 
behind the evolution of informed consent is the high consciousness 
over personal health and fitness. It is equally argued that the 
concept had evolved from the Nuremberg experiences. In fact the 
doctrine got wide acceptance only in the last few decades.20  The 
patients now are more cautious about the treatment administered 
to them and this was created by the new perception of the human 
right doctrine of bodily autonomy.  
Even though the doctrine of informed consent has been widely 
accepted and followed by almost all medical professionals it is yet 
to be formally structured. Two different standards have been 
evolved to deal with this issue and they are (1) the prudent patient 
test, (2) the reasonable doctor test. In the prudent patient test, the 
doctor has to disclose all those details which a cautious patient 
considers to be material from patient‟s standpoint. In reasonable 
doctor test the physician community tries to raise a unique 
standard from their side. Here the doctors have to disclose all the 
details which another doctor will do in the same instance. It is true 
that the doctrine succeeded in introducing better consensus 
between doctor and patient in medical treatment. The doctrine 
originated in an American case law.21 In this case, the claimant was 
subjected to a surgery in which there was an inherent danger of 
paralysis. The same was not informed by the surgeon and the 
patient was paralyzed. The court held the surgeon to be liable and 
there by developed the standard of informed consent. It was only 
few years prior to this judgment, the Nuremberg Code was 
adopted, where the concept of consent was discussed in detail in 
need of medical interventions. Nevertheless, the Code does not 
                                                          
19 Harvey Teff, Consent to Medical Procedures: Paternalism, Self-determination 
or Therapeutic Alliance?, 101 L.Q.R. 432 (1985). 
20 EDWARD P. RICHARDS AND KATHERINE C. RATHBUN, MEDICAL CARE LAW 
209 (Aspen Publishers 1999). 
21 Salgo v. Leland Stanford Jr. University Board of Trustees, 154 Cal. App. 
2d. 560 (1957). 
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demand such consent to be informed. The 2nd district Court of 
Appeal of California held that:22 
A physician violates his duty to his patient and subjects himself to 
liability if he withholds any facts which are necessary to form the 
basis of an intelligent consent by the patient to the proposed 
treatment. 
In America, the law clearly advocates for informed consent and the 
only dispute is on the mode of its application; either to go with 
prudent patient norm or with the reasonable doctor version. 
In England, the doctrine of informed consent was adopted through 
a high court judgment.23 By this judgment the court required the 
medical professionals to make it clear to the patient about the 
treatment and the risks involved in the treatment as every doctor 
would do in similar circumstances. Another decision from England 
is of importance as it involves multiple explanations for the 
doctrine of informed consent.24 
Informed consent itself is not well designed and judiciary has had 
various opinions on the extent of disclosure of facts relating to 
patient‟s health by a physician. Sidaway’s case25 talks much on that.  
Different standards were set by judges in the above case. Lord 
Scarman developed the test of prudent patient on the basis of a 
reasonable patient standard. By prudent patient test, the physician 
has an extensive duty of disclosure towards the patients. The only 
ground on which the physician can withhold the information is on 
therapeutic privilege. Therapeutic privilege allows the physician to 
withhold the details with regard to the treatment if it appears to be 
unfavourable to patient‟s physical or mental wellbeing. In contrast 
to the above opinion, Lord Diplock suggested the standard of a 
reasonably competent practitioner who always keeps his skill and 
judgment to improve the patient‟s health. The question of 
negligence towards informed consent will arise only if the 
                                                          
22 Id. at 575. 
23 Chatterton v. Gerson and Anr., 1 Q.B. 432 (1981). 
24 Sidaway v. Bethlem Royal Hospital Governors and Ors.,1 All E. R. 643 
(1985). 
25 Id.; See also JONATHAN MONTGOMERY, HEALTH CARE LAW 241 (Oxford 
University Press 1997).  
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nondisclosure of any matter generally appears to medical 
community with relevant expertise as inappropriate. Lord 
Templeman has given different opinion on the same matter. 
According to him, the final decision is always with the patient and 
the patient can have more information interacting with the 
physician. No patient can expect too much information as it will 
become an impediment to balanced judgment in medical treatment. 
The above variations in the judicial opinion itself indicate the 
complex nature of the doctrine of informed consent. Informed 
consent thus will fail to serve its actual intentions and objectives in 
clinical drug trials. The need for rethinking the doctrine of 
informed consent in clinical trials is envisaged as fundamental.26 
Research on this context effectively noticed the incapacity of the 
doctrine to serve as a universal norm. Any lapse in grasping 
information will also vitiate the accountability of informed consent. 
Hence it always falls short of public aspiration.27 
Informed Consent under Indian Law 
The Indian position on informed consent also evolved through 
many decisions. The law only maintains that the consent for 
treatment to be attained in circumstances where it is demanded and 
should be obtained in writing.28 The consumer law in India governs 
aspects of medical negligence also. The patient consciousness of 
their rights has improved in India. In reality, the law relating to 
informed consent is less understood and accepted in India and 
hence it is still in its infancy state. Only in few case laws the court 
reflected the idea of informed consent and thereby tried to design 
its legal premise. But as the time goes on, the doctrine of informed 
consent and its relevance in medical treatment is being realized by 
the judiciary and the society at large.  
Even in instances where the doctor failed to make the right 
treatment and thereby caused serious injuries to the patient; the 
                                                          
26 NEIL C. MANSON & ONORA O‟ NEILL, RETHINKING INFORMED CONSENT IN 
BIOETHICS 25 (Cambridge University Press, 2007). 
27 Id. at 154. 
28  The Indian Medical Council (Professional Conduct, Etiquette and 
Ethics) Regulations, 2002. 
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judiciary did not examine the relevance of taking informed consent 
from the patient. 29  In another case law the court held that the 
conditions for consent as stipulated by the Indian Contract Act 1872 
is to be complied with in medical treatment too.30 It was made the 
obligation of every doctor to ensure that he had taken consent from 
the patient by free and fair means.31 Even though the concept of 
informed consent is not well established by this judgment, it clearly 
focused on the importance of consent in medical treatment. The 
law relating to informed consent is clearly laid down by Supreme 
Court in Samira Kohli 32  judgment. The judgment mandates the 
physician to obtain real and valid consent from the patient before 
commencing the treatment. In the course of obtaining such consent 
the physician has to impart adequate knowledge that will help a 
patient to make a balanced decision. The doctor has to inform the 
patient about the nature and risk of the treatment and also about 
the alternatives available. Consent for diagnosis and therapeutic 
remedy are to be taken differently. 
Consent to Human Experiments 
Human experimentations were regulated with the doctrine of 
consent even before the Nuremberg Trials.33 The Neisser Case34 was 
of such kind where Albert Neisser, a dermatology professor made 
serum trials for patients with syphilis against their will or 
knowledge. The court demanded the need for consent from the 
patients despite the medical authority of Neisser in therapeutic care 
and was fined. In an advice to the ministry, the lawyers stated such 
trials would amount to criminal liability if done against the will of 
the patient in non therapeutic trials. 35  In 1931, as a part of its 
                                                          
29 Smt. Vinitha Ashok v. Laxshmi Hospital and Ors., 11 (1992) C.P.J. 372 
(N.C.). 
30 Punjabi Nursing Home v. Kailash Marodia, 11 (2003) C.P.J. 194. 
31 Id. at 195. 
32 Samira Kohli v. Prabha Manchanda and Anr., A.I.R. 2008 S.C. 1385. 
33  Jochen Vollmann & Rolf Winau, Informed Consent in Human 
Experimentation before the Nuremberg Code, 313 BRITISH MEDICAL JOURNAL 
1445 (1996). 
34 Id.  
35 Id. at 1446. 
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criminal law reform, the German government made new guidelines 
for new therapy and human experimentation which set out certain 
serious precautions.36 According to these guidelines new therapy 
can be introduced even without the consent of the patient in 
emergency situations. On the other hand non therapeutic research 
was only permitted after obtaining proper consent from the patient. 
It is remarked that these documents prior to the Nuremberg Code 
have even discussed the possibility of constituting institutional 
review boards but failed in the attempt.37 Thus it is evident that the 
doctrine of informed consent had its implications to some extent 
even before the Nuremberg Code.38 
Obtaining the patient‟s consent for clinical trials is mandatory but it 
is not an easy procedure. In formulating the informed consent from 
a patient, the crucial question arises about the extent of information 
that has to be made available to the patient about the trial. 
Explaining the impact of a new therapy even in the case of 
therapeutic trial is not that easy and is more complicated in non-
therapeutic trials. 39  As observed earlier, in this article, the 
expectation and grasping capacity of the patient will vary and the 
same cannot ever be an excuse to any adverse incident in the course 
of the trial. 40  In obtaining consent for experimentations always 
consent forms should be used which will help the researchers for 
future references before the ethical boards and the copy of the same 
is to be provided to the patient concerned. The presence of a 
witness will add more credibility to the consent so obtained.41 
The very presence of the word „informed‟ means someone who is 
instructed properly and knows the facts about the trial. In the case 
of clinical trial the word informed will not always have the same 
impact as used in the case of treatment. Normally in the case of 
randomized trials most of the information will not be adequately 
provided. It is also equally relevant to note that the law does not 
                                                          
36 Id. 
37 Id. 
38 Id. at 1447. 
39 Elizabeth Wager, Peter J.H. Tooley et. al., Get Patients’ Consent to Enter 
Trials, 311 BRITISH MEDICAL JOURNAL 734 (1995). 
40 Id. at 735. 
41 Id. at 736. 
P C Harigovind                                                                            ISSN 2278-4322 
12 
 
emphasize on the need of conveying all adequate information.42 
There exist some substantial differences between the processes of 
seeking informed consent and obtaining the same. Seeking the 
informed consent is only an ethical obligation but on the other side 
obtaining it depends upon the research involved in the process. The 
process of obtaining informed consent in most of the cases is taken 
as a bureaucratic form filling process and should not be like that.43 
The researcher has to put a design to the questions and 
explanations that has to be communicated to the trial subject. 
Communication and its precision make the entire basis for the 
nicety to the objective of informed consent. The legal principle of 
adequate information or reasonable information in the case of 
therapeutic care cannot be the one for experimentations. The 
researcher has to communicate whole information and make the 
trial subject convinced about the misfortunes in every trial.   
Legally, the consent given by the parties to a trial are to be free and 
informed. As we mentioned earlier this cannot be far and final 
criteria for adducing fairness for trial process. The so obtained 
informed consent should also be clear about the understanding of 
the trial subject about the project he is consenting to. Hans Jonas 
identifies this as the quality of the authentic consent. 44  The 
workability of the doctrine of informed consent is also dependent 
on the factors like the mindset of the investigator, the primacy 
given to the autonomy of the trial subject and the method adopted 
for the conversation.45 The rule of informed consent, demands the 
following disclosures to become a true consent: 
(1) that the subjects are not only patients and to the extent, to which 
they are patients, that their therapeutic interests, even if not 
                                                          
42 M. J. Peckham, Carolyn Faulderet et. al., Informed Consent: Ethical, Legal 
and Medical Implications for Doctors and Patients Who Participate in 
Randomized Clinical Trials, 286 BRITISH MEDICAL JOURNAL 1117, 1118 (1983). 
43 Elizabeth Wager, Peter J.H. Tooley et. al., Get Patients’ Consent to Enter 
Clinical Trials, 311 BRITISH MEDICAL JOURNAL 734, 737 (1995). 
44  Charles Fethe, Beyond Voluntary Consent: Hans Jonas on the Moral 
Requirements of Human Experimentation, 19 JOURNAL OF MEDICAL ETHICS 99, 
101 (1993). 
45 Jay Katz, Human Experimentation and Human Rights, 38 ST. LOUIS U.L.J. 7, 
28-34 (1993). 
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incidental, will be subordinated to scientific interests; (2) that it is 
problematic and indeterminate whether their welfare will be better 
served by placing their medical fate in the hands of physician 
rather than the investigator; (3) that in opting for the care of a 
physician they may be better or worse off (4) that clinical research 
will allow doctors to penetrate the mysteries of medicine‟s 
uncertainties about which treatments are best, dangerous or 
ineffective; (5) that research is governed by a research protocol and 
a research question and, therefore, his or her interests and needs 
will yield to the claims of science; (6) that physician investigators 
will respect whatever decision the subject ultimately makes. 46 
The above observations also have many drawbacks from the 
human rights standpoint. The conception that the therapeutic 
interest of the patient will be subordinated with scientific interest is 
presented with much vagueness. The impact of the same will vary 
depending on the stages in clinical trials. In phase I trial, the subject 
will not be having any therapeutic interest but only scientific or 
monetary interest. In the forthcoming stages, the extent of 
therapeutic interest is relative. There the trials subjects have to look 
for the alternative therapeutic cures for their disease or get 
properly convinced about the risk involved in the trial and the 
above contention by Jay Katz is concerned only about the latter.  
Analysing the fourth point, it seems that it will never become a 
concern for any research subject in spite of his status being a 
patient or non patient to reveal the safety and efficacy of any drug. 
All these points emphasize the incapability of the doctrine of 
informed consent to ensure human rights of trial subjects. 
Informed Consent in Clinical Trials: Role of Ethical Review 
Committees 
The law requires the regular monitoring and review of clinical 
trials so as to ensure the safety and dignity of trial subjects. 
Informed consent from the subject by itself is not a complete 
doctrine to protect the human rights of the subjects. From the very 
beginning of a trial there should be an exact scheme for the trial 
and the same is modeled through a research protocol. The protocol 
                                                          
46 Id. at 34. 
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preparation and the review of the same by the ethics committee 
impartial and independent of the research institution is envisaged 
in the international documents. The role of ethics committee is well 
maintained in the Helsinki Declaration adopted by the World 
Medical Organization. This being a document made by the medical 
community, it could be biased. The working of ethics committees 
are not dependent upon these international documents but on the 
national legislations. In India, the constitution of ethics committees 
is maintained in the Drugs and Cosmetics Rules 1945. Schedule Y 
of the said rules in its appendix details the scheme for the 
constitution of ethics committees. It states that only the person who 
chairs the committee should be independent of the research 
institution. Apart from this only two or three members are 
independent of medical fraternity. The entire process of clinical 
trial always helps the members of medical community to earn more 
and they will always tend to promote trials and will be the bad 
guardian of subject‟s rights. The committee should consist at least 
of seven members and there should be some members who 
represent the community of social scientists, NGOs, community 
and so on. These are the representatives of the ethics committee 
who can be the saviour of the human rights of trial subjects. 
Role of the Non-Governmental Organisations in Ethics 
Committee 
NGOs fight for human rights not only in India but also in many 
countries. In clinical trial also NGO‟s can act as the role player in 
the protection of rights of the trial subjects. This is also legally 
made possible through the constitution of ethics committees with 
the presence of NGO participation. The mere representation of an 
NGO member will not make the process of protocol review 
impartial and fair. The very nature of review of protocol and the 
monitoring of trial will be creating many technical barriers. The 
medical terminology used, side effects of drugs and even the very 
nature of components included in a trial drug cannot be easily 
identified by the representative of the NGO. This can only be 
possible by the inclusion of a trained and knowledgeable person as 
an NGO representative. Law either failed to foresee this aspect or 
resolutely avoided the same. The Indian law does not prescribe the 
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method through which the ethics committee is to be elected. In 
most cases the institution will include a person to favour their 
interest as an NGO representative.   
This dilemma can be overcome by few amendments to the existing 
law. The state shall maintain a list of qualified NGO‟s or social 
scientists having adequate qualification and knowledge about 
human rights, medicine, and side effects of various chemical 
compounds. This standard should also be introduced 
internationally. The United Nations Organization, World Medical 
Association and Red Cross Society can organise awareness 
programs or short term courses for educating these values. NGO 
members vote should be made crucial in deciding the fate of the 
trails and the national authorities like Drugs Control General of 
India should always keep a rapport with these NGO members of 
various ethics committees. The relevance of NGO intervention in 
clinical trial can be easily learned from the recent Indian 
experiences. The impact of unethical trials is brought to the notice 
of Indian Supreme Court by certain NGO‟s. Apart from the review 
of protocol, trained NGO‟s and their representatives can make the 
consent taking procedure more consistent and reasonable. NGO‟s 
role thus should be positively designed so as to enhance the human 
rights of trial subjects in clinical trials. NGO‟s can become a 
balancing factor against the excessive economic and professional 
interest of medical community. 
Conclusion 
The doctrine of informed consent emerged as milestone in the 
history of medical profession. Historically doctors were given 
eventual trust by the patient community for their concern for the 
wellbeing of patient community. 47  The bitter experiences of 
research activities conducted by the Nazi doctors lead to the 
invention of this doctrine. This doctrine may be sound enough to 
assure safety of the patients in the case of treatment. Above all this 
can be called as an American doctrine suited for a developed 
society. India is not yet fit to accommodate such a doctrine in need 
                                                          
47  MARK DAVIES, MEDICAL SELF-REGULATION 90 (Ashgate Publishing 
Company 2007).  
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of safety of her illiterate patient community. Looking back, the 
doctrine will appear as a contribution of judiciary and it is not yet 
having a specific form or definition. Many privileges which can be 
attracted by a physician in case of treatment cannot be extended to 
the case of experiments over human beings.48 In short, the doctrine 
in its present form cannot tackle the vulnerable position of trial 
subjects. Even the presence of strong research ethics committee 
cannot make the situation better. A codified piece of norms on 
informed consent and its rigid compliance is highly required.  
                                                          
48 SHAUN D. PATTINSON, MEDICAL LAW AND ETHICS 369 (Sweet and Maxwel 
2006). 
